We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Onto Innovation Inc. (ONTO - Free Report) reported healthy fourth-quarter 2020 results, wherein the top and the bottom lines beat the respective Zacks Consensus Estimate.
Net Income
On a GAAP basis, net income in the December quarter was $19.9 million or 40 cents per share against loss of $17.8 million or loss of 41 cents per share in the prior-year quarter. The improvement primarily resulted from operating income.
In 2020, net income was $31 million or 63 cents per share compared with $1.9 million or 6 cents per share in 2019.
Quarterly non-GAAP net income came in at $35.6 million or 72 cents per share compared with $18.1 million or 41 cents per share in the year-ago quarter. The bottom line beat the Zacks Consensus Estimate by 12 cents.
Onto Innovation Inc. Price, Consensus and EPS Surprise
Quarterly revenues totaled $155.1 million compared with $120.6 million in the year-ago quarter. The improvement was driven by strength in memory and Radio Frequency communications for the 5G handset ramp and the acceptance of the company’s new products. The top line surpassed the consensus estimate of $150 million.
Based on market segmentation, 42% of revenues were derived from specialty device and advanced packaging markets, 21% from software and services, and 37% from advanced nodes market.
In 2020, revenues surged 81.9% year over year to $556.5 million.
Other Details
Total operating expenses were $60.6 million compared with $62.9 million in the prior-year quarter. Non-GAAP gross profit was $84 million compared with $60.9 million a year ago with respective margins of 54% and 51%. The year-over-year increase was driven by a favorable product mix on the back of higher revenues. Non-GAAP operating income was $37.6 million compared with $20.2 million in the year-ago quarter.
Cash Flow & Liquidity
During the fourth quarter, Onto Innovation generated $32.6 million of cash from operations.
As of Dec 26, 2020, the company had $373.7 million in cash and cash equivalents with $83.3 million of non-current liabilities. This compares with the respective tallies of $320.2 million and $98.8 million a year ago.
Q1 Guidance
Onto Innovation has guided for the first quarter of 2021. The company expects revenues in the range of $155-$169 million. GAAP earnings per share (EPS) are expected in the range of 35-49 cents. Non-GAAP EPS are estimated in the band of 62-76 cents.
Zacks Rank & Other Stocks to Consider
Onto Innovation currently carries a Zacks Rank #2 (Buy).
Airgain delivered a trailing four-quarter positive earnings surprise of 62.5%, on average. The company’s earnings beat the Zacks Consensus Estimate in three of the last four quarters.
Knowles delivered a trailing four-quarter positive earnings surprise of 12.5%, on average.
U.S. Cellular delivered a trailing four-quarter positive earnings surprise of 231.1%, on average.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Onto Innovation (ONTO) Q4 Earnings & Revenues Beat Estimates
Onto Innovation Inc. (ONTO - Free Report) reported healthy fourth-quarter 2020 results, wherein the top and the bottom lines beat the respective Zacks Consensus Estimate.
Net Income
On a GAAP basis, net income in the December quarter was $19.9 million or 40 cents per share against loss of $17.8 million or loss of 41 cents per share in the prior-year quarter. The improvement primarily resulted from operating income.
In 2020, net income was $31 million or 63 cents per share compared with $1.9 million or 6 cents per share in 2019.
Quarterly non-GAAP net income came in at $35.6 million or 72 cents per share compared with $18.1 million or 41 cents per share in the year-ago quarter. The bottom line beat the Zacks Consensus Estimate by 12 cents.
Onto Innovation Inc. Price, Consensus and EPS Surprise
Onto Innovation Inc. price-consensus-eps-surprise-chart | Onto Innovation Inc. Quote
Revenues
Quarterly revenues totaled $155.1 million compared with $120.6 million in the year-ago quarter. The improvement was driven by strength in memory and Radio Frequency communications for the 5G handset ramp and the acceptance of the company’s new products. The top line surpassed the consensus estimate of $150 million.
Based on market segmentation, 42% of revenues were derived from specialty device and advanced packaging markets, 21% from software and services, and 37% from advanced nodes market.
In 2020, revenues surged 81.9% year over year to $556.5 million.
Other Details
Total operating expenses were $60.6 million compared with $62.9 million in the prior-year quarter. Non-GAAP gross profit was $84 million compared with $60.9 million a year ago with respective margins of 54% and 51%. The year-over-year increase was driven by a favorable product mix on the back of higher revenues. Non-GAAP operating income was $37.6 million compared with $20.2 million in the year-ago quarter.
Cash Flow & Liquidity
During the fourth quarter, Onto Innovation generated $32.6 million of cash from operations.
As of Dec 26, 2020, the company had $373.7 million in cash and cash equivalents with $83.3 million of non-current liabilities. This compares with the respective tallies of $320.2 million and $98.8 million a year ago.
Q1 Guidance
Onto Innovation has guided for the first quarter of 2021. The company expects revenues in the range of $155-$169 million. GAAP earnings per share (EPS) are expected in the range of 35-49 cents. Non-GAAP EPS are estimated in the band of 62-76 cents.
Zacks Rank & Other Stocks to Consider
Onto Innovation currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the broader industry are Airgain (AIRG - Free Report) , Knowles (KN - Free Report) and U.S. Cellular (USM - Free Report) , each carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Airgain delivered a trailing four-quarter positive earnings surprise of 62.5%, on average. The company’s earnings beat the Zacks Consensus Estimate in three of the last four quarters.
Knowles delivered a trailing four-quarter positive earnings surprise of 12.5%, on average.
U.S. Cellular delivered a trailing four-quarter positive earnings surprise of 231.1%, on average.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>